Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis
- 1 November 2006
- journal article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 65 (11), 1438-1443
- https://doi.org/10.1136/ard.2006.051979
Abstract
Polymyalgia rheumatica (PMR) may create some difficulties in the differential diagnosis of elderly-onset rheumatoid arthritis (EORA) and of EORA with PMR-like onset (EORA/PMR). To investigate possible differences between three groups of patients, with regard to serum levels of inflammatory cytokines and steroidal hormones at baseline and after 1 month of treatment with glucocorticoids (prednisone 7.5-12.5 mg/day). 14 patients with PMR, 15 with EORA and 14 with EORA/PMR, as well as 15 healthy, matched controls were analysed. Tumour necrosis factor alpha (TNFalpha), interleukin (IL)6, IL1 receptor antagonist (IL1Ra), cortisol, dehydroepiandrosterone sulphate (DHEAS) and 17-hydroxy-progesterone (PRG) were evaluated. Serum levels of both TNFalpha and IL6 were significantly higher in all three groups of patients than in controls (p<0.01). Serum IL6 levels were significantly higher in patients with both PMR and EORA/PMR than in patients with EORA (p<0.05). IL1Ra serum levels were significantly higher in patients with EORA than in controls (p<0.001) and in patients with PMR and EORA/PMR (p<0.05). DHEAS was significantly lower in patients with EORA/PMR than in those with EORA (p<0.05). PRG was significantly higher in all patient groups (p<0.05). After glucocorticoid treatment, serum TNFalpha and IL6 levels significantly decreased in all patient groups; IL1Ra significantly increased in patients with PMR and in those with EORA/PMR; cortisol, DHEAS, and PRG significantly decreased in patients with PMR and in those with EORA/PMR (p<0.05). Different cytokine and steroidal hormone patterns suggest that patients with PMR and those with EORA/PMR seem to be have a more intensive inflammatory reaction and are more efficient responders to glucocorticoid treatment than patients with EORA.Keywords
This publication has 39 references indexed in Scilit:
- Polymyalgia rheumaticaBest Practice & Research Clinical Rheumatology, 2004
- Protective effects of IL-1Ra or vIL-10 gene transfer on a murine model of wear debris-induced osteolysisGene Therapy, 2004
- Long‐term anti–tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretionArthritis & Rheumatism, 2003
- Elderly Onset Rheumatoid Arthritis Complicated by Polymyalgia Rheumatica.Internal Medicine, 2002
- Musculoskeletal manifestations in polymyalgia rheumatica and temporal arteritisAnnals Of The Rheumatic Diseases, 2001
- Presenting features of polymyalgia rheumatica (PMR) and rheumatoid arthritis with PMR-like onset: a prospective studyAnnals Of The Rheumatic Diseases, 2001
- Long term treatment of polymyalgia rheumatica with deflazacort.Annals Of The Rheumatic Diseases, 1994
- A seasonal pattern in the onset of polymyalgia rheumatica.Annals Of The Rheumatic Diseases, 1990
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Low plasma androgens in women with systemic lupus erythematosusArthritis & Rheumatism, 1987